Cyprus childhood vaccine schedule: 11 vaccines by age
For babies (first year): Hepatitis B, DTaP / Tdap, Polio (IPV), Hib, Pneumococcal (PCV), Influenza (flu). Click a vaccine for its schedule in every other country.
| Vaccine | Status | Doses & recommended age |
|---|---|---|
| Hepatitis B · side effects & data | Universal | Dose 1 — 2-3 months (6-in-1 (DTaP-IPV-Hib-HepB)) Dose 2 — 4-5 months (6-in-1 (DTaP-IPV-Hib-HepB)) Dose 3 — 6-8 months (6-in-1 (DTaP-IPV-Hib-HepB)) Birth dose — Within 12 hours of birth, with HBIG (only infants of HBsAg-positive mothers) |
| DTaP / Tdap · side effects & data | Universal | Dose 1 — 2-3 months Dose 2 — 4-5 months Dose 3 — 6-8 months Dose 4 — 18-20 months Dose 5 — 4-6 years Booster — 11-12 years (Tdap) |
| Polio (IPV) · side effects & data | Universal | Dose 1 — 2-3 months (IPV) Dose 2 — 4-5 months (IPV) Dose 3 — 6-8 months (IPV) Dose 4 — 18-20 months (IPV) Dose 5 — 4-6 years (IPV) |
| Hib · side effects & data | Universal | Dose 1 — 2-3 months Dose 2 — 4-5 months Dose 3 — 6-8 months Booster — 18-20 months |
| Pneumococcal (PCV) · side effects & data | Universal | Dose 1 — 2 months (PCV15 or PCV20) Dose 2 — 4 months (PCV15 or PCV20) Dose 3 — 6 months (PCV20 schedule only) Booster — 11-15 months (PCV15) or 12-15 months (PCV20) |
| Meningococcal · side effects & data | Universal | Dose 1 — 12 months (MenACWY) Dose 2 — 11-12 years (MenACWY) |
| MMR · side effects & data | Universal | Dose 1 — 12-15 months Dose 2 — 4-6 years |
| Varicella (chickenpox) · side effects & data | Universal | Dose 1 — 12-15 months Dose 2 — 4-6 years |
| Hepatitis A · side effects & data | Universal | Dose 1 — 24 months Dose 2 — 30 months |
| HPV · side effects & data | Universal | Dose 1 — 9-13 years (HPV9, girls and boys) Dose 2 — 6 months after dose 1 (HPV9, girls and boys) |
| Influenza (flu) · side effects & data | Universal | Annual — 6 months-15 years, every season; to 17 years with chronic conditions |
Cyprus vaccine schedule vs. the United States
Cyprus and the United States share 11 routine vaccines. The U.S. routinely gives Rotavirus, COVID-19, which Cyprus does not.
| Vaccine | Cyprus first dose | U.S. first dose | Doses |
|---|---|---|---|
| Hepatitis B | 2-3 months | Birth | 3 vs 3 doses |
| DTaP / Tdap | 2-3 months | 2 months | 6 vs 5 doses |
| Polio (IPV) | 2-3 months | 2 months | 5 vs 4 doses |
| Hib | 2-3 months | 2 months | 4 vs 4 doses |
| Pneumococcal (PCV) | 2 months | 2 months | 4 vs 4 doses |
| Meningococcal | 12 months | 11-12 years | 2 vs 2 doses |
| MMR | 12-15 months | 12-15 months | 2 vs 2 doses |
| Varicella (chickenpox) | 12-15 months | 12-15 months | 2 vs 2 doses |
| Hepatitis A | 24 months | 12-23 months | 2 vs 2 doses |
| HPV | 9-13 years | 11-12 years | 2 vs 2 doses |
| Influenza (flu) | 6 months-15 years, every season; to 17 years with chronic conditions | 6 months and older, every season | 1 vs 1 doses |
In the routine U.S. schedule but not Cyprus's: Rotavirus, COVID-19.
Coverage and reported disease in Cyprus
WHO/UNICEF estimates of how many children actually receive each vaccine, and the diseases' reported incidence, from the WHO Immunization Data portal.
- Measles: 24 reported cases, 17.5 per million people (2025). Two-dose coverage is 98%; sustained elimination needs roughly 95% coverage with both doses.
- Pertussis (whooping cough): 3 reported cases, 2.2 per million people (2025).
- Hepatitis B birth dose: no current coverage figure reported to WHO. A birth dose matters most where mothers commonly carry hepatitis B; countries with universal prenatal screening often start hepatitis B vaccination later or target only exposed newborns.
Coverage: share of children who received each vaccine
| Vaccine | Cyprus | United States |
|---|---|---|
| DTP dose 1 | 99% (2025) | 98% (2025) |
| DTP dose 3 | 98% (2025) | 94% (2025) |
| Measles dose 1 | 91% (2025) | 92% (2025) |
| Measles dose 2 | 98% (2025) | 95% (2025) |
| Polio (IPV series) | 98% (2025) | 93% (2025) |
| Hep B birth dose | not reported | 75% (2025) |
| Hep B dose 3 | 98% (2025) | 93% (2025) |
| Hib dose 3 | 98% (2025) | 92% (2025) |
| Pneumococcal (PCV) | 83% (2025) | 84% (2025) |
| Rotavirus (complete) | not reported | 77% (2025) |
| HPV dose 1, girls | 71% (2025) | 73% (2025) |
Source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), falling back to country-reported figures, and WHO/UNICEF Joint Reporting Form reported cases, via the WHO Immunization Data portal (21 October 2026). "Not reported" usually means the vaccine is not in the universal schedule. Year-by-year series and data-quality grades: Cyprus disease-risk profile.
Other Europe countries
Denmark · Finland · France · Germany · Italy · Norway · Poland · Spain · Sweden · United Kingdom · Hungary · all 34 countries